By proceeding, you agree to our Terms of Use and Privacy Policy.
Raphael Clynes, MD, PhD, Vice President of Translational Biology, Xencor. Dr. Clynes is a medical oncologist/hematolo-gist and a cellular immunologist with more than 100 publications in cancer and autoimmunity. Prior to joining Xencor in 2017, Dr.
Talks About #biology
Preferred Locations #NorthAmerica
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.
